Loading...
A two-centre audit on changes in ejection fraction (EF) following sequential anthracycline chemotherapy and trastuzumab (T) in patients with HER2+early breast cancer (EBC).
Fernando, S Conway, A Mitchell, H Sandri, I Okonta, L Mansi, J
Fernando, S
Conway, A
Mitchell, H
Sandri, I
Okonta, L
Mansi, J
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017-03
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A two-centre audit on changes in ejection fraction (EF) following sequential anthracycline chemotherapy and trastuzumab (T) in patients with HER2+early breast cancer (EBC). 2017, 32(Suppl 1): S128 The Breast